A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn ’s Disease

ConclusionsPatients who are predicted to have accelerated baseline CZP clearance are at risk of subtherapeutic CZP concentrations. Patient-level probabilities for a composite remission outcome can be predicted for patients with CD by entering commonly available patient- and disease-related factors into an online CDST (https://premedibd.com) incorporating predicted CZP clearance.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research